HEPATITIS B VIRUS SURFACE ANTIGEN (HBSAG) - ANVISA Registration 10071770939

Access comprehensive regulatory information for HEPATITIS B VIRUS SURFACE ANTIGEN (HBSAG) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10071770939 and manufactured by ABON BIOPHARM (HANGZHOU) CO LTD. The registration is held by ABBOTT DIAGNOSTICOS RAPIDOS S.A. with validity until Dec 11, 2033.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, ABBOTT IRELAND DIAGNOSTICS DIVISION, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.